Our nutraceuticals
Nanyang Biologics CareViva
CareViva is our scientifically-backed nutraceutical brand dedicated to addressing cancer and metabolic diseases. We uphold rigorous standards of quality, innovation, and integrity in every product, enabling our customers to make informed choices for a healthier life.
Are you interested in a B2B partnership for product distribution?
Are you interested in a B2B partnership for product distribution?
Cancer Care
CareViva Natural Support
Herbal ingredients: Clinacanthus Nutans, Strobilanthes Crispus, Elephantopus Scaber
Problem: DNA damage response (DDR) networks maintain genome integrity in the cell. Cancer cells frequently accumulate mutations in DDR genes and targeting DDR can induce excessive DNA damage. Synthetic lethality refers to the combination of a mutated gene, e.g. responsible for DNA repair, with the inactivation of another gene or its product, which together are toxic and induce cell death.
Solution: CareViva NS formulation is effective in preclinical studies to prevent tumour growth by inducing synthetic lethality in cancer cells
Problem: DNA damage response (DDR) networks maintain genome integrity in the cell. Cancer cells frequently accumulate mutations in DDR genes and targeting DDR can induce excessive DNA damage. Synthetic lethality refers to the combination of a mutated gene, e.g. responsible for DNA repair, with the inactivation of another gene or its product, which together are toxic and induce cell death.
Solution: CareViva NS formulation is effective in preclinical studies to prevent tumour growth by inducing synthetic lethality in cancer cells

Cardiovascular Health
CareViva CardiViva

Herbal ingredients: Vernonia Amygdalina Delile, Alternanthera Sessilis
Problem: Excessive lipid and cholesterol uptake causes build-up of cholesterol ester in macrophage, leading to foam cell formation. Foam cells lead to plaque development on artery wall, eventually resulting inatherosclerosis. High LDL is a risk factor for atherosclerosis.
Solution: CardiaViva formulation is effective in preclinical studies to prevent foam cell formation by reducing cholesterol ester level and inflammation in macrophages.
Problem: Excessive lipid and cholesterol uptake causes build-up of cholesterol ester in macrophage, leading to foam cell formation. Foam cells lead to plaque development on artery wall, eventually resulting inatherosclerosis. High LDL is a risk factor for atherosclerosis.
Solution: CardiaViva formulation is effective in preclinical studies to prevent foam cell formation by reducing cholesterol ester level and inflammation in macrophages.
Adipose Health
CareViva AdiCare
Herbal ingredients: Centella Asiatica, Alternanthera Sessilis
Problem: White fat (bad fat) stores excess fatty acids as triglycerides in lipid droplets. Brown fat (good fat) metabolizes fatty acids and dissipates the energy as heat. Browning of white fat improves whole body metabolism of glucose and fat, reducing risk of metabolic syndrome.
Solution: The AdiCare formulation is effective in preclinical studies tofacilitate browning, increase lipolysis and reduce lipid in white fat
Problem: White fat (bad fat) stores excess fatty acids as triglycerides in lipid droplets. Brown fat (good fat) metabolizes fatty acids and dissipates the energy as heat. Browning of white fat improves whole body metabolism of glucose and fat, reducing risk of metabolic syndrome.
Solution: The AdiCare formulation is effective in preclinical studies tofacilitate browning, increase lipolysis and reduce lipid in white fat

Liver health
CareViva LivHealth

Herbal ingredients: Strobilanthes Crispus, Centella Asiatica, Alternanthera Sessilis
Problem: Fatty liver happens in 40% of the adult population, and can be asymptomatic at the stage of simple steatosis. Lifestyle change may reverse the progression. Lipotoxic stress leads to hepatocytes death, and inflammation. Drug intervention is needed to reverse steatohepatitis. If left untreated it will irreversibly progress to cirrhosis, when liver transplant is the only cure.
Solution: The LivHealth formulation is effective in preclinical studies to induce lipid clearance, prevent lipotoxic damage and improve insulin sensitivity in hepatocytes
Problem: Fatty liver happens in 40% of the adult population, and can be asymptomatic at the stage of simple steatosis. Lifestyle change may reverse the progression. Lipotoxic stress leads to hepatocytes death, and inflammation. Drug intervention is needed to reverse steatohepatitis. If left untreated it will irreversibly progress to cirrhosis, when liver transplant is the only cure.
Solution: The LivHealth formulation is effective in preclinical studies to induce lipid clearance, prevent lipotoxic damage and improve insulin sensitivity in hepatocytes
Featured news
No items found.